Safe Care CommitmentGet the latest news on COVID-19, the vaccine and care at Mass General.Learn more
If you’ve ever stayed up late angrily commenting on Twitter posts, eating a whole pint of ice cream out of the container, finishing another bottle of wine, or just feeling miserable, you might identify with the Mind After Midnight hypothesis.
More research is needed to understand the neurophysiological changes in the brain that occur when we’re awake during the circadian night.
We recently interviewed Maria Loscertales, 53, to learn about her experience since contracting COVID-19 in 2021, and participation in a McCance observational study to better understand Long-COVID.
Recientemente entrevistamos a María Loscertales, de 53 años, para hablar sobre su experiencia desde que contrajo COVID-19 en 2021 y su participación en un estudio observacional de McCance para obtener información sobre el síndrome de COVID19 post-agudo.
2022-7-long-covid-clinical-trial. 2022-7-long-covid-clinical-trial. Dr. Edmarie Guzmán-Vález has been studying the effects of a vitamin B3 complex on symptoms of long-COVID. Her passion for sience is equaled by her passion for inspiring young
2022-07-brain-care-score-launched-through-virtual-group-visits. 2022-07-brain-care-score-launched-through-virtual-group-visits. In partnership with the MGH Revere Healthcare Center, a community based primary and specialty-care center, the McCance
Because the size of the anterior mid-cingulate cortex is greater in SuperAgers than in typical older adults, it could be a marker for strategies to mitigate the risk and consequences of post-operative delirium.
Mass General Neurology is pleased to announce that Grace Croty, MD has received a 2022 Clinical Research Training Scholarship in Parkinson's Disease, funded by the Parkinson's Foundation and American Brain Foundation, in collaboration with the American Academy of Neurology.
New study offers the first evidence of replay during sleep in the human motor cortex, which governs voluntary movement.
Last week, the US Food and Drug Administration’s (FDA) Cellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC) unanimously endorsed a new therapy for early active cerebral adrenoleukodystrophy (CALD).
The Patient Gateway provides secure online access to your health information whenever you need it. Check upcoming appointments, communicate with your doctor’s office, review medications and pay medical bills—all seamlessly online 24/7.